Quantcast

Latest Prostate Cancer Foundation Stories

2010-05-19 09:45:00

Drugs should be developed to target gene fusions in prostate cancer, research shows Prostate cancer treatments that target the hormone androgen and its receptor may be going after the wrong source, according to a new study. Researchers have found that when two genes fuse together to cause prostate cancer, it blocks the receptor for the hormone androgen, preventing prostate cells from developing normally. The study, from the University of Michigan Comprehensive Cancer Center, suggests...

2010-05-03 10:50:00

Chesapeake Urology Associates Research Scholar Program Helping Local Docs Succeed WASHINGTON, May 3 /PRNewswire-USNewswire/ -- Proceeds from the 2009 Great Prostate Cancer Challenge® in Baltimore (GPCC) will be used to support the American Urological Association Foundation Chesapeake Urology Scholar Fund. ZERO - The Project to End Prostate Cancer, in partnership with Chesapeake Urology Associates, PA, has donated $45,000 to the American Urological Association...

2010-04-28 11:16:00

Television personalities Jim Huber and Craig T. Nelson make first stock purchases; Dollar-for-dollar stock match offered through generosity of the Schwartz Family WASHINGTON, April 28 /PRNewswire-USNewswire/ -- ZERO - The Project to End Prostate Cancer leads the fight to eliminate this most commonly diagnosed cancer among men. By promoting greater awareness of the need for early detection and leveraging public resources for life-saving research and new treatments for those with advanced...

2010-04-20 09:30:00

Early Screening Imperative for African American Males CHICAGO, April 20 /PRNewswire-USNewswire/ -- With African American males having a prostate cancer incidence rate that's sixty percent higher than that of white males, and a mortality rate that's more than double that of white males, it's vital to the overall health of the African American population to increase awareness of prostate cancer and encourage early screening for the disease. "During Minority Cancer Awareness week we need to...

2010-04-15 08:25:10

An experimental drug is showing promise for the treatment of men with an aggressive form of advanced prostate cancer. A new multicenter study has concluded that the targeted therapy MDV3100 is safe and effective for patients with castration-resistant prostate cancer (CRPC), known for its poor prognosis and limited treatment options. The research, led by investigators at Memorial Sloan-Kettering Cancer Center, appears early online and in an upcoming edition of The Lancet. According to the...

2010-04-13 11:49:00

PORTLAND, Ore., Apr. 13 /PRNewswire-USNewswire/ -- Evan Denhart the son of the late Hanna Andersson co-founder, Tom Denhart, has established the Prostate Awareness Research Foundation (PAR for Life) in his father's memory. This national foundation is dedicated to eliminating death from prostate cancer - the disease that took Denhart's life in April 2009 after a 14-year battle. "After experiencing first hand the impact of prostate cancer I felt strongly that there existed a need to raise...

2010-03-31 10:26:00

Supporters from across the U.S. will convene Sept. 14-16 to emphasize importance of research funding and access to care WASHINGTON, March 31 /PRNewswire-USNewswire/ -- Advocates in the fight against prostate cancer are encouraged to register now for the 2010 Summit to End Prostate Cancer, the only annual summit on Capitol Hill that specifically focuses on prostate cancer. The two-day Summit is packed with more than 100 meetings with elected officials and discussions with leaders in the...

2010-03-11 13:13:00

PSA Test Is to Men What the Mammogram Is to Women American Cancer Society Twists Facts to Stay in Business WASHINGTON, March 11 /PRNewswire-USNewswire/ -- When it comes to the documented 40 percent effectiveness of PSA testing in preventing death from prostate cancer, neither the American Cancer Society nor the discoverer of the PSA protein, Richard Ablin, are telling the public the complete story. "The American Cancer Society is a 'false prophet' when it comes to telling the truth...

2010-03-10 12:07:13

Shahriar Koochekpour, MD, PhD, Assistant Professor of Microbiology and Immunology, Biochemistry and Molecular Biology, and Genetics at LSU Health Sciences Center New Orleans, led research that has discovered, for the first time, a genetic mutation in African-American men with a family history of prostate cancer who are at increased risk for the disease. Dr. Koochekpour, who is also a member of the LSUHSC Stanley S. Scott Cancer Center, identified an inheritable genetic defect in the receptor...

2010-03-03 16:14:00

WASHINGTON, March 3 /PRNewswire-USNewswire/ -- Members of America's Prostate Cancer Organizations are concerned that the issuance this morning of yet another set of new guidelines on screening for prostate cancer is only adding to the confusion most men already feel about whether they should or shouldn't be tested for the most common form of cancer in American men. "It is time for us all to come together and make one, straightforward recommendation about screening and early detection of...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related